CWF19L2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.368000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.233400E-01
Normal-vs-Stage2
2.684200E-01
Normal-vs-Stage3
1.822160E-01
Normal-vs-Stage4
9.659800E-01
Stage1-vs-Stage2
6.771600E-01
Stage1-vs-Stage3
6.398000E-01
Stage1-vs-Stage4
1.469760E-01
Stage2-vs-Stage3
3.966800E-01
Stage2-vs-Stage4
2.210600E-01
Stage3-vs-Stage4
1.016590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.377400E-01
Normal-vs-AfricanAmerican
5.626200E-01
Normal-vs-Asian
7.719600E-02
Caucasian-vs-AfricanAmerican
4.965200E-01
Caucasian-vs-Asian
7.880200E-02
AfricanAmerican-vs-Asian
1.064830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.669200E-01
Normal-vs-Female
2.135200E-01
Male-vs-Female
8.473000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.449170E-01
Normal-vs-Age(41-60Yrs)
4.021400E-01
Normal-vs-Age(61-80Yrs)
2.128200E-01
Normal-vs-Age(81-100Yrs)
5.926100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.749190E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.692600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.773830E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.021500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.018230E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.929800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.762020E-01
Normal-vs-Daily Drinker
1.940820E-01
Normal-vs-Weekly Drinker
5.426500E-02
Normal-vs-Occasional Drinker
3.652800E-01
Normal-vs-Social Drinker
3.724400E-01
Non Drinker-vs-Daily Drinker
8.084800E-01
Non Drinker-vs-Weekly Drinker
3.943000E-01
Non Drinker-vs-Occasional Drinker
2.292000E-01
Non Drinker-vs-Social Drinker
6.688600E-01
Daily Drinker-vs-Weekly Drinker
5.828200E-01
Daily Drinker-vs-Occasional Drinker
1.983780E-01
Daily Drinker-vs-Social Drinker
5.742400E-01
Weekly Drinker-vs-Occasional Drinker
4.639700E-02
Weekly Drinker-vs-Social Drinker
2.957200E-01
Occasional Drinker-vs-Social Drinker
5.873200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.553200E-01
Normal-vs-Grade 2
3.793500E-02
Normal-vs-Grade 3
4.742300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.634200E-02
Grade 1-vs-Grade 3
6.855500E-03
Grade 1-vs-Grade 4
2.553200E-01
Grade 2-vs-Grade 3
1.359180E-01
Grade 2-vs-Grade 4
3.793500E-02
Grade 3-vs-Grade 4
4.742300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.570180E-01
Normal-vs-NonDiabetic
1.594040E-01
Diabetic-vs-NonDiabetic
8.641000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.494000E-02
Normal-vs-NoPancreatitis
1.908630E-01
Pancreatitis-vs-NoPancreatitis
5.972800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.675200E-01
Normal-vs-N1
2.599000E-01
N0-vs-N1
6.880600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.020800E-01
Normal-vs-TP53-NonMutant
3.143000E-01
TP53-Mutant-vs-TP53-NonMutant
1.847000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
